)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Kairos Pharma (KAPA) investor relations material
Kairos Pharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary14 Nov, 2025
Executive summary
Focused on advancing immunotherapy and cell therapy for oncology, with no approved products or revenue to date.
Net loss of $4,082K for the nine months ended September 30, 2025, reflecting increased R&D and G&A expenses.
Operations funded primarily through equity and debt financings, including a $3,058K private placement and $3,602K from an equity line of credit.
Cash and cash equivalents of $5,575K and shareholders' equity of $7,664K as of September 30, 2025.
Financial highlights
Research and development expenses rose to $1,597K for the nine months ended September 30, 2025, up from $242K year-over-year, mainly due to a Phase 2 prostate cancer trial.
General and administrative expenses increased to $2,560K from $655K year-over-year, driven by higher vendor advance amortization and insurance costs.
Net loss per share was $(0.23) for the nine months ended September 30, 2025, compared to $(0.15) in the prior year.
No revenue generated in the reporting period.
Outlook and guidance
Current cash reserves expected to fund operations for at least 12 months from the filing date.
Anticipates continued operating losses and increased expenses as clinical programs advance.
Ongoing need for additional capital to support operations and growth strategy.
Lonza agreement: ENV105 Phase 3 timeline impact
Key drivers of R&D expense increase
Novation agreements: strategic rationale
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Kairos Pharma earnings date
Q4 202515 Apr, 2026
Next Kairos Pharma earnings date
Q4 202515 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Kairos Pharma Ltd is a biopharmaceutical company focused on the development of cancer therapies. The company is engaged in researching and advancing novel treatments targeting various types of cancer through immunotherapy, targeted therapy, and combination approaches. The company is headquartered in Los Angeles, California, and its shares are listed on the OTC markets.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage